J&J Reorganizes DePuy Synthes, Eliminates Jobs
This article was originally published in The Gray Sheet
Executive Summary
The move, which includes about 400 job cuts and 80 new positions, is a response to “seismic shifts” in the health care market, the company said.
You may also be interested in...
More Mergers As A Direct Result Of Medtronic-Covidien Combo? Mixed Prospects
Medtronic’s massive acquisition of Covidien could accelerate the trend of industry consolidation further, some say. But executives from several big device firms insist nothing fundamental has changed.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.